Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Fielmann shows chart-technical recovery potential after weak start to the year

Fielmann shares rose sharply after a buy recommendation from Deutsche Bank; the chart suggests a completed base formation and possible substantial recovery. Operationally, the company remained below usual growth rates in Q1 with a slight revenue increase to €613m and stable adjusted EBITDA of €149m, which management attributed to extreme weather events. Fielmann confirmed its full-year guidance of 5–7% revenue growth and an adjusted EBITDA margin of 23% as well as its mid-term plan to nearly double revenue by 2030 with a 25% margin. The stock appears historically cheap with a KGV 2026 of around 16 and could be interesting for longer-term investors. » More on finanzen.net
Fielmann expects 5–7% sales growth in 2026 with adjusted Ebitda margin around 23%

Fielmann forecasts a 5–7% increase in sales for 2026 to €2.55–2.6 billion and an adjusted Ebitda of about €590–610 million (margin roughly 23%). Investments in expansion and the rollout of AI‑assisted refraction technology, along with broader availability of eye tests in the US, should support growth but will weigh on margins in the short term. In the first quarter, sales rose 1.3% to €613 million, while adjusted Ebitda was almost unchanged at €149 million; extreme weather events temporarily hit business. » More on finanzen.net
Fielmann sees marked rise in demand after BofA buy recommendation

A buy recommendation from Bank of America is driving the Fielmann share, which at times rose by more than 6 percent and settled at a chart barrier around €45. BofA sees lower risks, highlights accelerated growth in the US and regards the share price level as historically low. The sales target of four billion euros for 2030 is not yet priced into market expectations; additionally, Fielmann benefits from low dependence on oil prices and low freight costs. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, FIELMANN AG (ADR/1/5)O.N. has already paid €0.28 in dividends. The last payout was in August.

Financials

In the last quarter, FIELMANN AG (ADR/1/5)O.N. had revenue of €634.9m and net profit of €55.81m

(EUR)	June 2026	YoY
Revenue	634.9m	1.92%
Gross profit	502.67m	2.24%
Net profit	55.81m	7.99%
EBITDA	114.65m	15.38%

Fundamentals

Metric	Value
Market capitalization	€3.64bn
Number of shares	419.29m
52-week high/low	€12.71 - €7.67
Dividend yield	3.32%
Dividends TTM	€0.28
Beta	0.62
P/E ratio	17.34
PEG ratio	0.72
P/B ratio	3.32
P/S ratio	1.49

Company profile

Fielmann Aktiengesellschaft, together with its subsidiaries, engages in the investment in and operation of optical and hearing aid businesses. The company manufactures and sells visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses and accessories, and various merchandise, as well as hearing aids and accessories. As of December 31, 2021, it operated 693 stores, including 610 in Germany, 45 in Switzerland, 38 Austria, 3 in Luxembourg, 43 in Italy, 37 in Poland, 87 in Spain, 32 in Slovenia, and 15 in the rest of Europe. The company also 78 smaller locations in Eastern Europe. It also offers its products through online stores. The company was founded in 1972 and is headquartered in Hamburg, Germany. Fielmann Aktiengesellschaft is a subsidiary of Korva SE.